Additionally, changes in the treatment of T2DM practice over time, especially the introduction of SGLT2 inhibitors in 2012 by the European Medicines Agency, might be another reason for the increased incidence of UTIs in the diabetes mellitus cohort [24,25]. This evidence concerns the gene SLC5A2 and type 2 diabetes mellitus.